A

Abingworth Portfolio holdings

AUM $307M
This Quarter Return
+8.41%
1 Year Return
+93.6%
3 Year Return
+207.29%
5 Year Return
+452.78%
10 Year Return
–
AUM
$181M
AUM Growth
+$181M
Cap. Flow
+$36.3M
Cap. Flow %
20%
Top 10 Hldgs %
98.25%
Holding
13
New
2
Increased
–
Reduced
–
Closed
–

Top Buys

1
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
$33.3M
2
RGLS
Regulus Therapeutics
RGLS
$2.94M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 43.71%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
RNA
1
DELISTED
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
$34.9M 19.23% 6,213,924 – –
DRNA
2
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$33.3M 18.38% +1,182,196 New +$33.3M
SUPN icon
3
Supernus Pharmaceuticals
SUPN
$2.53B
$32.1M 17.74% 3,600,000 – –
PTLA
4
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$32.1M 17.73% 1,240,912 – –
AMRN
5
Amarin Corp
AMRN
$311M
$14.6M 8.08% 8,087,486 – –
CEMP
6
DELISTED
Cempra, Inc.
CEMP
$8.24M 4.55% 714,285 – –
ACHV icon
7
Achieve Life Sciences
ACHV
$152M
$7.09M 3.91% 603,740 – –
ZGNX
8
DELISTED
Zogenix, Inc.
ZGNX
$6.63M 3.66% 2,335,218 – –
GWPH
9
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$6.07M 3.35% 102,200 – –
RGLS
10
DELISTED
Regulus Therapeutics
RGLS
$2.94M 1.62% +327,350 New +$2.94M
HPTX
11
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
$1.61M 0.89% 62,500 – –
ANTH
12
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$1.47M 0.81% 437,994 – –
ZLCS
13
DELISTED
ZALICUS INC COM NEW
ZLCS
$96K 0.05% 78,966 – –